Dispenser des anticancéreux oraux à l’officine. Contraintes professionnelles et pistes d’actions (notice n° 1004477)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03873cam a2200349 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250125134928.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Marmorat, Thibaud |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Dispenser des anticancéreux oraux à l’officine. Contraintes professionnelles et pistes d’actions |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2017.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 5 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Objectif : Du fait des évolutions thérapeutiques et organisationnelles de la prise en charge du cancer, de nouveaux enjeux apparaissent dans le suivi des patients atteints de cancer à l’officine. Notre étude a pour objectif de mieux comprendre la manière dont les pharmaciens d’officine définissent leur rôle dans la prise en charge des patients atteints de cancer, et identifier les leviers d’action favorisant une coordination plus efficiente avec les autres acteurs de la cancérologie. Méthodes : Fondés sur une approche qualitative, des entretiens semi-directifs ont été menés auprès de 19 pharmaciens d’officine. Les données ont été analysées sur la base d’une analyse thématique. Résultats : Les explications sur les traitements suivis par le patient sont largement reprises par les pharmaciens (53 %). Les participants de cette étude ont évoqué les demandes des patients concernant les effets secondaires (79 %) et les médecines complémentaires (37 %). Des difficultés impactant le suivi des patients sont aussi explicitées, tel que le manque d’information médicale pour le traitement contre le cancer (21 %) et concernant leur relation avec l’hôpital (26 %). Conclusion : La mise à disposition d’outils d’information partagés par l’ensemble des acteurs de la prise en charge semble ainsi déterminante pour lever les difficultés du suivi du patient par le pharmacien d’officine. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Dispensing of oral anticancer drugs by retail pharmacies: professional requirements and recommendations Objectives : As a result of organizational and therapeutic progress in the management of cancer, retail pharmacies are faced with numerous challenges in the follow-up of cancer patients. This study was designed to provide a better understanding of the way in which retail pharmacists define their role in the management of cancer patients and to identify actions that would promote more efficient coordination with other oncology professionals. Methods : Semi-structured qualitative interviews were conducted with retail pharmacists and data were analysed by thematic analysis. Results : The majority (53%) of retail pharmacists provide patients with explanations concerning their treatments. Participants in this study described in detail patients’ questions concerning adverse effects (79%) as well as certain forms of alternative medicine (37%). Difficulties with an impact on patient follow-up were also reported, such as the lack of medical information concerning cancer treatments (21%) and their relationship with the hospital (26%). Conclusion : The availability of information tools shared by all healthcare professionals therefore appears to be essential to address the difficulties of follow-up of cancer patients by retail pharmacists. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | rôle professionnel |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pharmacies |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tumeurs |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pharmaciens d’officine |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | recherche qualitative |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pharmacies |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | retail pharmacists |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | qualitative research |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pharmacists |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | neoplasms |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | professional role |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Canat, Hélène Labrosse |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Préau, Marie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Farsi, Fadila |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Santé Publique | 29 | 1 | 2017-03-06 | p. 89-93 | 0995-3914 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-sante-publique-2017-1-page-89?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-sante-publique-2017-1-page-89?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux